Addex Therapeutics (ADXN) FCF Payout Ratio (2019 - 2026)
Addex Therapeutics (ADXN) posted FCF Payout Ratio of 1.22 for Q1 2026, up 74.13% sequentially from 4.72 in Q1 2025, and up 74.13% YoY from 0.7 in Q1 2025.
Addex Therapeutics (ADXN) FCF Payout Ratio (2019 - 2026) Analysis & Trends
Addex Therapeutics has reported FCF Payout Ratio for 8 years, with the latest figure at 1.22 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.07 |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | -1.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 |
| Mar 31, 2025 | -4.72 |
| Sep 30, 2024 | 0.08 |
| Jun 30, 2024 | 0.98 |
| Mar 31, 2024 | -0.74 |
| Sep 30, 2023 | 1.07 |
| Jun 30, 2023 | -1.40 |
| Mar 31, 2023 | -2.37 |
| Sep 30, 2022 | -0.60 |
| Jun 30, 2022 | 1.04 |
| Mar 31, 2022 | -3.07 |
| Sep 30, 2021 | 1.03 |
| Jun 30, 2021 | 1.10 |
| Mar 31, 2021 | -9.12 |
| Sep 30, 2020 | 1.12 |
| Jun 30, 2020 | 1.05 |
| Mar 31, 2020 | -6.53 |
| Sep 30, 2019 | 0.34 |
| Jun 30, 2019 | -1.02 |
| Mar 31, 2019 | 15.26 |